InvestorsHub Logo

crookedneck

01/16/15 3:07 PM

#11648 RE: nbm16yankees #11647

Here is the interview nbm, and you are correct, which is why I have been hammering Mr. James to put that info out in a PR. So far it has been seen by just few and there is no reason why he couldn't have shared this same information in a PR, which would have helped to boost the share price when it was most needed, before it dipped below $.031, triggering the removal of the floor price. Its the main reason I am so upset. I have asked him numerous times to PR this, but to date he has ignored my request and said he would issue a PR when there was something newsworthy to report. Well I know of nothing more noteworthy than sharing that kind of info with investors. Problem is that he just doesn't understand the OTC market and what it takes to keep your share price from falling, which is talking about the company's future and where they are headed. It gives investors a reason to buy and hold. An otc stock without news and/or forward looking views get taken to the cleaners. Hopefully we can force him to change his approach that is killing the stock. Cheers!

crookedneck Member Level Monday, 12/22/14 03:32:38 PM
Re: None
Post # of 11647
This interview gives you a good idea what lies ahead for NRTI next year. Here are some IMPORTANT QUOTES from that interview that you MUST remember - know what you own and why! Holiday Cheers!

VERY IMPORTANT quotes from the 10/2/2014 interview w/NRTI's Management:

1) "It is one of those rare opportunities for us and we should be a first market mover in the marketplace(Cannabinoid Nutriceuticals)."Stated CMO Jim Kras.

2) One company that we could have direct competition with down the road is GW Pharmaceuticals (GWPH). Stated CMO Jim Kras in reference to the CBD Market.

3) "Being a first market mover is an advantageous position to be in, but you have to make sure when you do come to market you are defined on where you want to go." Stated CEO Michael James in reference to the CBD Market.

4) "We are coming out with products that are going to help people, we are going to bring a whole new line of innovation to the marketplace". Stated CEO Michael James in reference to the CBD Market.

5) We are not only going to be the gold standard, but we are going to bring standardization to the industry as a function of having our medical advisory board. Stated CMO Jim Kras in reference to the CBD Market. Dr. Michelle Sexton who has helped write the monograph on CBD, is working directly with Carl Germano our Chief Science Officer to make sure we set and keep quality and consistency to the highest standards.

6) A doctor now see’s the CBD arena and believe that this can help my patients. Now they can see an innovative company with a top formulator that has spent years in due diligence and scientific background creating the highest quality standard formula available. Stated CMO Jim Kras.

7) I had multiple conversation with TRTC CEO Derek Peterson about coming out with a product that does not have thc but has just CBD or different cannabinoids that can help people. We then entered into an agreement that we would source cbd from TRTC. Stated CEO Michael James.

8) From there we decided to put together a medical advisory board. We had the initial meeting in Belvidere, NJ and everyone flew in for that. We spoke about dosages and what targets we were looking into whether it be nausea, eating disorder, pain management and a whole bunch of different things that everyone spoke about. Stated CEO Michael James.

9) We think a lot of the business is being ignored, we feel we have done a fantastic job in the last two years by diversifying the revenue base. We have the Surgex Brand, Bikini ready brand, Slim Trim Brand, Martha Stewart Brand and you look at the demographics buying these products. Then when we go to CBD it could really be anyone of any age taking this product. Today we are at 17,000+ doors and most of that has been done in nine months. Those distributions throughout the country will help us when we come out with our CBD product. Stated CEO Michael James.

10) We have not disclosed that(type of CBD product lines) to the public yet, but we will be launching this product line in 2015. We want to under promise and over deliver. Stated CEO Michael James.

To read the entire interview go here: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=106924772

LOTS OF EXCITING THINGS AHEAD FOR NRTI AS THEY ENTER THE MEDICAL MARIJUANA SPACE VERY SOON! Cheers!